Odyssey Health (ODYY) Shareholder's Equity Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -63.95% |
| Oct 31, 2025 | -13.96% |
| Jul 31, 2025 | -30.39% |
| Apr 30, 2025 | -185.07% |
| Jan 31, 2025 | -174.54% |
| Oct 31, 2024 | -0.97% |
| Jul 31, 2024 | 13.36% |
| Apr 30, 2024 | 235.38% |
| Jan 31, 2024 | 261.56% |
| Oct 31, 2023 | -15.50% |
| Jul 31, 2023 | -32.57% |
| Apr 30, 2023 | -42.66% |
| Jan 31, 2023 | -28.48% |
| Oct 31, 2022 | -79.71% |
| Jul 31, 2022 | -67.80% |
| Apr 30, 2022 | -330.85% |
| Jan 31, 2022 | -311.15% |
| Oct 31, 2021 | -444.71% |
| Jul 31, 2021 | -324.78% |
| Apr 30, 2021 | 22.91% |
| Jan 31, 2021 | 0.95% |
| Oct 31, 2020 | 37.26% |
| Jul 31, 2020 | -9.72% |
| Apr 30, 2020 | -25.36% |
| Jan 31, 2020 | -11.12% |
| Oct 31, 2019 | 1.38% |
| Jul 31, 2019 | 27.54% |
| Apr 30, 2019 | -29.93% |
| Jan 31, 2019 | -519.75% |
| Oct 31, 2018 | -83.93% |
| Jul 31, 2018 | -95.15% |
| Apr 30, 2018 | -95.83% |
| Jan 31, 2018 | 172.08% |
| Oct 31, 2017 | -63.11% |
| Jul 31, 2017 | -71.78% |
| Apr 30, 2017 | -85.50% |
| Jan 31, 2017 | -52.99% |
| Oct 31, 2016 | -61.65% |
| Jul 31, 2016 | -54.40% |
| Jul 31, 2015 | -6,704.13% |